General Information of the Compound
| Compound ID |
CP0417095
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
[(3aR,6aS)-2-(5-chloro-1,3-benzoxazol-2-yl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl]-[5-chloro-2-(triazol-2-yl)phenyl]methanone
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C22H18Cl2N6O2
|
||||||||||||||||||
| Molecular Weight |
469.332
|
||||||||||||||||||
| Canonical SMILES |
Clc1ccc(c(c1)C(=O)N1C[C@H]2CN(C[C@H]2C1)c1nc2cc(Cl)ccc2o1)-n1nccn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C22H18Cl2N6O2/c23-15-1-3-19(30-25-5-6-26-30)17(7-15)21(31)28-9-13-11-29(12-14(13)10-28)22-27-18-8-16(24)2-4-20(18)32-22/h1-8,13-14H,9-12H2/t13-,14+
Show/Hide
|
||||||||||||||||||
| InChIKey |
LULPIXQVSHYLQL-OKILXGFUSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01132, Orexin receptor type 2
Protein ID: PT02001, Orexin/Hypocretin receptor type 1